FG
VRTX icon

Foster Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Foster Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
575
+81
+16% +$35.9K 0.01% 251
2026
Q1 		$221K Buy
+494
New +$230K 0.01% 256
2025
Q3 		– Sell
-462
Closed -$206K – 283
2025
Q2 		$206K Sell
462
-63
-12% -$29K 0.01% 250
2025
Q1 		$255K Buy
+525
New +$245K 0.01% 178

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Foster Group's VRTX Position: Q2 2026 in Review

Foster Group increased its Vertex Pharmaceuticals (VRTX) stake by 16% in Q2 2026, buying an estimated $35.9K and bringing the position to 575 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #251.

Foster Group first reported a position in VRTX in Q1 2025 and has held it in 4 quarters since. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Foster Group held 575 shares of Vertex Pharmaceuticals worth $286K as of Q2 2026.
  • Foster Group bought 81 Vertex Pharmaceuticals shares in Q2 2026, an estimated $35.9K.
  • Vertex Pharmaceuticals made up 0.01% of Foster Group's portfolio in Q2 2026, its #251 holding.
  • Foster Group first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.